InvestorsHub Logo
icon url

XenaLives

03/04/18 3:23 PM

#143311 RE: MycroftHolmes #143310

Very helpful, thank you.

icon url

McMagyar

03/05/18 9:50 AM

#143442 RE: MycroftHolmes #143310

mycroft..
interesting that our new Board member has extensive knowledge of the
genetic side of the business..Interleukin..
icon url

Investor2014

03/05/18 11:42 AM

#143471 RE: MycroftHolmes #143310

Interesting indeed.

The company seems to be saying that they have identified genetic biomarkers that will be applicable not just to AD, but also for the Rett and PD trials.

Do you believe that the SIGMAR1 gene in various combinations (like with/without APOE expression) is potentially a common predictor of response in any indication for A2-73?